TL;DR: Atomic Alchemy is a Y Combinator Winter 2019 startup We produce cancer-curing materials used in nuclear medicine., currently acquired with a team of 8.
We produce cancer-curing materials used in nuclear medicine.
Last verified:
Atomic Alchemy is building a bank of reactors to produce the nuclear material that goes into nuclear medicine. Radiopharmaceuticals are vitally important in biological tracers, diagnostic imaging, and cancer treatments. Currently, the world's supply of Molybdenum-99, the cornerstone of 80% of all nuclear medicine procedures, is sourced from just six government-run, scientific research reactors abroad. Five of these reactors are 45-65 years old and are quickly coming to the end of their operational life. This has cultivated a fragile and lengthy supply chain, at odds with the nature of radioactive material. This issue and its implications do not just effect molybdenum, but any other reactor-based isotope. Many promising cancer therapies are stuck in clinical trials, unable to secure enough…
Built by LemStudio
Yes. Atomic Alchemy was funded by Y Combinator in the Winter 2019 batch. We produce cancer-curing materials used in nuclear medicine.
Atomic Alchemy is building a bank of reactors to produce the nuclear material that goes into nuclear medicine. Radiopharmaceuticals are vitally important in biological tracers, diagnostic imaging, and cancer treatments. Currently, the world's supply of Molybdenum-99, the cornerstone of 80% of all nuclear medicine proc…
Atomic Alchemy was part of Y Combinator's Winter 2019 batch.
Atomic Alchemy has a team of 8 people according to Y Combinator's directory.
Atomic Alchemy is currently listed as Acquired with a team of 8 in Y Combinator's directory.
Loading interactive view…